MedTrace Logo

NEUROlogical Prognosis After Cardiac Arrest in Kids

NCT03574025 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2018-06-29

No results posted yet for this study

Summary

Each year around 2000 children have a cardiac arrest in the United Kingdom (UK) and approximately one fifth are admitted to Pediatric Intensive Care Unit. Many of these children eventually die and among those who survive, some will be left with brain damage which could affect their quality of life. Currently, it is difficult for doctors to predict how much brain damage there is at an early stage after cardiac arrest and if this will improve in time.

NEURO-PACK aims to follow up children 3 months after their cardiac arrest to assess their quality of life and current functional status (has the child returned to usual routine as before cardiac arrest/mild disability, can the child not participate in certain activities as they were before the cardiac arrest/moderate disability, or if the child has near to no mobility/severe disability). Investigators will find this out by using a questionnaire and the research team will telephone patients and their families 3 months after the child's cardiac arrest. This telephone call should take no longer than 30 minutes. This will then be analysed and will help towards constructing a tool which will help doctors to predict which children who have had a cardiac arrest may survive with minimal brain damage.

Conditions

  • Cardiac Arrest

Interventions

OTHER

Questionnaire

To telephone the patient/family to look into how the patient is doing, moderate/severe brain damage.

Sponsors & Collaborators

  • University of Birmingham

    lead OTHER

Principal Investigators

  • Barney Scholefield · Birmingham Women's and Children's Hospital

Eligibility

Min Age
24 Hours
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-05-31
Completion
2019-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03574025 on ClinicalTrials.gov